BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 04:58 pm
Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve PFA the notice of Board ....
Advik Laboratories Ltd · 531686
✦ AI SummaryResults
Advik Laboratories Ltd has scheduled a board meeting on 13th August 2026 to consider and approve the un-audited financial results for the quarter ended 30th June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Advik Laboratories Ltd - 531686 - Board Meeting Intimation for Notice Of Board Meeting To Consider The Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June, 2026
Attachments (1)
📄pdf
Download →
28be759d-947c-4375-8366-0d4f7be91df1.pdf
View document text
MPS PHARMAA LIMITED
(Formerly Advik Laboratories Limited)
Dated: 04-08-2026
The Manager (Listing),
BSE Limited,
01st Floor, P.J. Towers
Dalal Street, Mumbai – 400001
Sub: Notice of Board Meeting to consider the Un-Audited Financial Results of the company for the
quarter ended 30thJune, 2026
Ref : BSE Scrip Code 531686; ASE Scrip Code- 01636 (ADVIK LABO)
Dear Sir/Madam,
Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice
is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India
(LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on
Thursday, 13th August,2026 at 12:00 P.M. at the corporate office of the company at 703, Arunachal Building,
19, Barakhambha Road, Connaught Place, New Delhi-110001,to inter-alia, consider and approve the Un-
Audited Financial Results of the Company & Limited Review Report thereon for the quarter ended 30thJune,
2026 and to carry on any other business with the permission of the Board.
Further, pursuant to BSE Circular no. LIST/COMP/01/2019-20 dated April 02, 2019 and in accordance with
Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the SEBI
(Prohibition of Insider Trading) Regulation, 2015, the trading window for dealing in the shares of the
Company for all Directors/Officers/Designated Employees of the Company and their relatives, is already
closed for the purpose of declaration of Un-Audited Financial Results for the quarter ended 30thJune, 2026.
Accordingly, the trading window of the company shall remain closed till 15th August, 2026.
This is for your information and records please.
Thanking You.
Yours Faithfully,
For MPS Pharmaa Limited
(Formerly Advik Laboratories Limited)
Pooja Chuni
Company Secretary
The Manager (Listing)
Ahmedabad Stock Exchange Limited
01st Floor, Kamdhenu Complex
Opp. Sahajanand College,
Panjara Pole, Ambawadi, Ahmedabad – 380015
CIN No. : L74899HR1994PLC038300
Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001
Phones: 011-42424884, 43571040-45, Fax: 011-43571047
Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana
Phones: 0124-2362471 Email:info@mpspharmaa.comWebsite: www.mpspharmaa.com